Wilbanks Smith & Thomas Asset Management LLC Twist Bioscience Corp Transaction History

Wilbanks Smith & Thomas Asset Management LLC

$3.54 Billion
Q1 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$38.58 - $83.27 $206,750 - $446,243	-5,359 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$75.47 - $135.88 $161,128 - $290,103	2,135 Added 66.22%	5,359 $415,000
Q3 2021 Nov 04, 2021	BUY	$95.64 - $131.48 $308,343 - $423,891	3,224 New	3,224 $345,000

Others Institutions Holding TWST

# of Institutions

256

Shares Held

66.8M

Call Options Held

127K

Put Options Held

45.4K

Artisan Partners Limited Partnership Milwaukee, WI

6.02M
Shares

$254 Million
0.43% of portfolio
Vanguard Group Inc Valley Forge, PA

5.62M
Shares

$237 Million
0.0% of portfolio
Black Rock Inc. New York, NY

5.42M
Shares

$229 Million
0.01% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

5.36M
Shares

$226 Million
2.3% of portfolio
Invesco Ltd. Atlanta, GA

3.64M
Shares

$154 Million
0.03% of portfolio

View Full List

About Twist Bioscience Corp

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.38B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

More about TWST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilbanks Smith & Thomas Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilbanks Smith & Thomas Asset Management LLC with notifications on news.

Account